Tri-Heal Max 45mg TB-500 25mg + BPC-157 10mg + KPV 10mg

Tri-Heal Max 45 mg is supplied as a high-purity multi-peptide research compound intended exclusively for scientific and laboratory applications. For research use only — not for human or veterinary use.  

Product Overview

Tri-Heal Max is a research blend combining BPC-157, KPV and Thymosin Beta 4 (TB-500) in a single lyophilized preparation designed for controlled laboratory investigation. The combination brings together three extensively studied peptide compounds frequently referenced in scientific literature involving peptide signalling systems, cellular communication pathways and molecular regulatory mechanisms. This preparation contains independently verified quantities of BPC-157, KPV and TB-500 supplied in a sealed research vial. Lyophilization helps preserve peptide stability and supports reliable laboratory handling and reconstitution. Due to its multi-peptide composition and comprehensive analytical verification, Tri-Heal Max represents a research material suitable for advanced peptide-focused investigations.  

Peptide Overview

Tri-Heal Max contains three distinct peptide components that are commonly investigated within controlled laboratory environments. BPC-157 is frequently examined in experimental peptide research involving molecular signalling pathways and peptide-mediated cellular communication systems. KPV is a short peptide fragment that has become a recognised research compound within experimental models exploring peptide interactions and regulatory pathways. Thymosin Beta 4 (TB-500) is among the most widely studied peptides in scientific literature and continues to be utilised in experimental investigations involving peptide-mediated biological processes. The combination of these three compounds allows researchers to investigate multiple peptide signalling systems within a single experimental framework.  

Historical Background and Scientific Context

Scientific interest in peptide research expanded significantly during the late twentieth century as advances in analytical chemistry and molecular biology enabled researchers to characterise increasingly complex peptide structures. The development of modern chromatographic and mass spectrometry techniques provided scientists with the ability to verify peptide identity, purity and molecular composition with high precision. BPC-157, KPV and Thymosin Beta 4 subsequently emerged as recognised compounds within peptide-focused scientific literature and continue to be investigated across numerous laboratory disciplines. The availability of multi-peptide preparations has enabled researchers to evaluate multiple signalling systems simultaneously within controlled experimental environments.  

Mechanistic Focus in Research

Within controlled laboratory environments, Tri-Heal Max is commonly studied in relation to peptide-mediated signalling pathways and molecular communication systems. Research investigations frequently explore the blend in experimental models examining:

• Peptide signalling pathways
• Cellular communication systems
• Molecular regulatory mechanisms
• Peptide interaction dynamics
• Intracellular signalling networks
• Comparative peptide investigations
• Multi-peptide pathway modelling

These experimental approaches allow researchers to investigate complex molecular processes involving multiple peptide signalling systems.  

Analytical Verification (COA)

Each batch of Tri-Heal Max supplied by Grail Formula undergoes independent third-party laboratory verification to confirm peptide identity, assay content, purity and microbiological safety. Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic, microbiological and mass spectrometry techniques. Batch: GF-THMAX-B241

• BPC-157 Assay: 13.51 mg
• KPV Assay: 10.01 mg
• Thymosin Beta 4 (TB-500) Assay: 34.9 mg
• BPC-157 Purity: greater than 99.8 percent
• KPV Purity: greater than 99.8 percent
• TB-500 Purity: greater than 99.8 percent
• BPC-157 Identification by RT: 0.995
• KPV Identification by RT: 0.996
• TB-500 Identification by RT: 0.995
• Molecular Ion Mass Identification (BPC-157): 1418 Da
• Molecular Ion Mass Identification (KPV): 343 Da
• Molecular Ion Mass Identification (TB-500): 4963 Da
• Bacterial Endotoxins: below 0.001 EU/mg
• Total Aerobic Microbial Count: Not detected
• Total Yeast and Mold Count: Not detected

Independent elemental impurity screening confirmed no detectable arsenic, cadmium, mercury, lead, nickel, vanadium or cobalt. These analytical procedures provide confirmation of identity, purity, traceability and batch consistency for laboratory research applications. :contentReference[oaicite:0]{index=0}  

Research Applications

In controlled laboratory environments, Tri-Heal Max may be utilised in experimental models designed to investigate peptide signalling systems and multi-peptide molecular pathways. Examples of research applications include:

• Multi-peptide signalling research
• Peptide interaction analysis
• Molecular communication studies
• Cellular pathway investigations
• Comparative peptide research
• Signal transduction modelling
• Controlled in vitro peptide studies

These applications are intended exclusively for scientific investigation and laboratory experimentation.  

Grail Formula Quality

Every Grail Formula research compound is supported by extensive independent analytical verification and full batch traceability. Each batch undergoes testing for:

• Peptide identity confirmation
• Assay content verification
• Purity assessment
• Molecular mass verification
• Endotoxin analysis
• Microbial contamination screening
• Heavy metal screening
• Batch traceability

Independent testing helps ensure consistent laboratory-grade research material suitable for controlled scientific applications.  

When You Choose Grail Formula

When selecting Grail Formula, researchers gain access to independently verified research compounds supported by detailed Certificates of Analysis and transparent batch-specific testing. Our commitment to quality includes publication of assay data, purity verification, identity confirmation, endotoxin screening, microbial testing, elemental impurity analysis and molecular mass verification. Every batch is supported by a downloadable COA issued by Liquilabs s.r.o. Czechia, providing full traceability and independent laboratory verification.  

Research Use Limitation

• Used solely for laboratory and in vitro research
• Not approved for human consumption
• Not approved for veterinary use
• Not intended for diagnostic purposes
• Not intended for therapeutic applications
• Not permitted for clinical administration
• For research use only

• Independently analysed by Liquilabs s.r.o. Czechia
• BPC-157 assay verified at 13.51 mg
• KPV assay verified at 10.01 mg
• TB-500 assay verified at 34.9 mg
• Purity greater than 99.8 % confirmed for all peptides
• Molecular ion mass identification confirmed for all components
• Endotoxin level below 0.001 EU/mg
• No detectable heavy metals or microbial contamination
• Multi-peptide research blend
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.